Clincosm LogoSign in Get a demo

A Survey Exploring Health and Screening Tests in People Treated for Hodgkin Lymphoma

Sponsor
The Christie NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT04996862
Collaborator
(none)
165
Enrollment
1
Location
3.9
Actual Duration (Months)
42.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A survey of health beliefs and cancer screening behaviour and intentions in Hodgkin lymphoma survivors

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A survey of Hodgkin lymphoma survivors registered in a follow-up database, examining health beliefs (using Health Belief Model) around breast, bowel and lung cancer screening, previous screening uptake and future uptake intentions

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    165 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Study of Health Beliefs and Cancer Screening Behaviours and Intentions in Hodgkin Lymphoma Survivors
    Actual Study Start Date :
    Jun 1, 2021
    Actual Primary Completion Date :
    Sep 28, 2021
    Actual Study Completion Date :
    Sep 28, 2021

    Outcome Measures

    Primary Outcome Measures

    1. The psychosocial factors predictive of uptake of breast, bowel and lung cancer screening in HL survivors [At baseline visit]

      Questionnaires

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Details held in the ADAPT database at The Christie NHS Foundation trust

    • Aged 18-80

    • Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years

    • Treated with radiotherapy and/or alkylating agent containing chemotherapy

    Exclusion Criteria:
    • Have previously stated they do not wish to be contacted for research

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Christie NHS Foundation Trust Manchester United Kingdom M204BJ

    Sponsors and Collaborators

    • The Christie NHS Foundation Trust

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The Christie NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT04996862
    Other Study ID Numbers:
    • CFTSp195
    First Posted:
    Aug 9, 2021
    Last Update Posted:
    Sep 29, 2021
    Last Verified:
    Sep 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Lymphoma
    Hodgkin Disease

    Study Results

    No Results Posted as of Sep 29, 2021